Cardiovascular Risk Factors

C-reactive proteins: Should everyone be tested?

Published in Medical Letter on the CDC and FDA, August 17th, 2003

In the last year, a number of studies have focused on the C-reactive protein (CRP) inflammatory risk factor for heart disease. Using high-sensitivity assays (hsCRP), scientists can now measure CRP at lower levels than previously possible.

These low levels of CRP (hsCRP) are related to chronic, low-grade inflammation, which is associated with heart disease. Many of these studies reported on the relationship of hsCRP to first myocardial or anginal attack, recurrence of coronary heart disease incidents, and increased prognosis of heart disease when elevated hsCRP exists with other risk factors. Other published materials have focused on the laboratory methods used for...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2003-08-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry